Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation

Dominguez, Antonia A., Lim, Wendell A., Qi, Lei S.·2016·Nature Reviews Molecular Cell Biology
DOI 10.1038/nrm.2015.2

Cited by (834)

Items 401–500 of 834

  1. Application of the CRISPRi system to repress sepF expression in Mycobacterium smegmatis
    Jing Xiao, Hongyan Jia, Liping Pan, Zihui Li, Lingna Lv, Boping Du, Lanyue Zhang, Fengjiao Du, Yinxia Huang, Tingming Cao et al. · 2018 · Infection Genetics and Evolution
  2. FAM72, Glioblastoma Multiforme (GBM) and Beyond
    Nguyen Thi Thanh Ho, Chinmay Satish Rahane, Subrata Pramanik, Pok‐Son Kim, Arne Kutzner, Klaus Heese · 2021 · Cancers
  3. History and Classification of CRISPR/Cas System
    Zulqurnain Khan, Zulfiqar Ali, Asif Ali Khan, Tahmina Sattar, Ali Zeshan, Tahira Saboor, Barkha Binyamin · 2022 · Springer eBooks
  4. PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA
    Yao Fan, Yi Liang, Yu Liu, Hui Fan · 2022 · Cell Death and Disease
  5. EpiCRISPR targeted methylation of Arx gene initiates transient switch of mouse pancreatic alpha to insulin-producing cells
    Marija Đorđević, Peter Stepper, Clarissa Feuerstein-Akgoz, Clarissa Gerhäuser, Verica Paunović, Anja Tolić, Jovana Rajić, Svetlana Dinić, Aleksandra S. Uskoković, Nevena Grdović et al. · 2023 · Frontiers in Endocrinology
  6. Advances in CRISPR/Cas gene therapy for inborn errors of immunity
    Xin-Yi Liu, Guang-Lei Li, Yin Liu, Fu-Ling Zhou, Xingxu Huang, Kui Li · 2023 · Frontiers in Immunology
  7. YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B
    Shijiang Wang, Jiangbo Nie, Kaiying Xu, Yangyang Liu, Weilai Tong, Anan Li, Wei Zuo, Zhili Liu, Feng Yang · 2023 · Aging
  8. How to use CRISPR/Cas9 in plants: from target site selection to DNA repair
    Adéla Přibylová, Lukáš Fischer · 2024 · Journal of Experimental Botany
  9. Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
    Elizabeth Maria Clarissa, Mamata Karmacharya, Hyunmin Choi, Sumit Kumar, Yoon‐Kyoung Cho · 2025 · Small
  10. MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells
    Silvana Opp, Daniel A. S. A. Vieira, Bianca Schulte, Sumit K. Chanda, Felipe Diaz‐Griffero · 2015 · Journal of Virology
  11. What rheumatologists need to know about CRISPR/Cas9
    GARY J. GIBSON, Maozhou Yang · 2017 · Nature Reviews Rheumatology
  12. Applications of CRISPR genome editing technology in drug target identification and validation
    Quinn Lu, George P. Livi, Sundip S. Modha, Kosuke Yusa, Ricardo Macarrón, David J. Dow · 2017 · Expert Opinion on Drug Discovery
  13. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells
    Paolo Petazzi, Raúl Torres-Ruiz, A Fidanza, Heleia Roca-Ho, Francisco Gutiérrez‐Agüera, Julio Castaño, Sandra Rodríguez, Rafael Díaz de la Guardia, Belén López‐Millán, Anna Bigas et al. · 2020 · Molecular Therapy — Nucleic Acids
  14. Rationally-engineered reproductive barriers using CRISPR & CRISPRa: an evaluation of the synthetic species concept in Drosophila melanogaster
    Andrew J. Waters, Paolo Capriotti, David C. A. Gaboriau, Philippos Aris Papathanos, Nikolai Windbichler · 2018 · Scientific Reports
  15. Evasion of Pre-Existing Immunity to Cas9: A Prerequisite for Successful Genome Editing In Vivo?
    Wignakumar, Thirushan, Fairchild, Paul J. · 2019 · Current Transplantation Reports
  16. Impact of gene editing on the study of cystic fibrosis
    Patrick T. Harrison, David J. Sanz, Jennifer A. Hollywood · 2016 · Human Genetics
  17. Selective Enrichment of Slow-Growing Bacteria in a Metabolism-Wide CRISPRi Library with a TIMER Protein
    Dominik Beuter, José Vicente Gomes‐Filho, Lennart Randau, Francisco Díaz-Pascual, Knut Drescher, Hannes Link · 2018 · ACS Synthetic Biology
  18. A Photolabile Semiconducting Polymer Nanotransducer for Near‐Infrared Regulation of CRISPR/Cas9 Gene Editing
    Yan Lyu, Shasha He, Jing Li, Yuyan Jiang, He Sun, Yansong Miao, Kanyi Pu · 2019 · Angewandte Chemie
  19. Progress and challenges in applying CRISPR/Cas techniques to the genome editing of trees
    Solme Pak, Chenghao Li · 2022 · Forestry Research
  20. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells
    Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, Silvia Blacher, Laurent Massotte, Emmannuel Di Valentin, Denis Furling, Nicolas Albert Gillet et al. · 2023 · Molecular Therapy — Nucleic Acids
  21. Large scale microfluidic CRISPR screening for increased amylase secretion in yeast
    S. Andreas Johansson, Thierry Dulermo, Cosimo Jann, Justin Smith, Anna Pryszlak, Georges Pignède, Daniel Schraivogel, Didier Colavizza, Thomas Desfougères, Christophe Rave et al. · 2023 · Lab on a Chip
  22. Functional genetic characterization of stress tolerance and biofilm formation in Nakaseomyces ( Candida ) glabrata via a novel CRISPR activation system
    Laetitia Maroc, Hajer Shaker, Rebecca S. Shapiro · 2024 · mSphere
  23. CRISPR activation to characterize splice-altering variants in easily accessible cells
    Thorkild Terkelsen, Nanna S. Mikkelsen, Ebbe Norskov Bak, Johan Vad‐Nielsen, Jenny Blechingberg, Simone Weiss, Simon Opstrup Drue, Henning Andersen, Brage Storstein Andresen, Rasmus Otkjær Bak et al. · 2024 · The American Journal of Human Genetics
  24. Genome-wide Cas9-mediated screening of essential non-coding regulatory elements via libraries of paired single-guide RNAs
    Yufeng Li, Min-Kang Tan, Almira Akkari-Henić, Limin Zhang, M. Kip, Sheng-Nan Sun, Jorian J. Sepers, Ningning Xu, Yavuz Ariyurek, S. Kloet et al. · 2024 · Nature Biomedical Engineering
  25. Chromatin Manipulation and Editing: Challenges, New Technologies and Their Use in Plants
    Kateryna Fal, Denisa Tomková, Gilles Vachon, Marie‐Edith Chabouté, Alexandre Berr, Cristel C. Carles · 2021 · International Journal of Molecular Sciences
  26. Prospects for engineering dynamic CRISPR–Cas transcriptional circuits to improve bioproduction
    Jason T. Fontana, William E. Voje, Jesse G. Zalatan, James M. Carothers · 2018 · Journal of Industrial Microbiology & Biotechnology
  27. CRISPR‐Cas9–induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression
    Matthew J. Roberston, Suchi Raghunathan, Vladimir N. Potaman, Fan Zhang, M. David Stewart, Bradley K. McConnell, Robert John Schwartz · 2019 · The FASEB Journal
  28. Advanced genome editing strategies for manipulation of plant specialized metabolites pertaining to biofortification
    Sweta Bhambhani, Kirtikumar Ramesh Kondhare, Ashok Prabhakar Giri · 2021 · Phytochemistry Reviews
  29. Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome
    Robert Lersch, Rawan Jannadi, Leonie Grosse, Matias Wagner, Marius Frederik Schneider, Celina von Stülpnagel, Florian Heinen, Heidrun Potschka, Ingo Borggraefe · 2022 · The Neuroscientist
  30. CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy
    Yinying Pu, Wencheng Wu, Huijing Xiang, Yu Chen, Huixiong Xu · 2022 · Nano Today
  31. Specific multivalent molecules boost CRISPR-mediated transcriptional activation
    Rui Chen, Xinyao Shi, Xiangrui Yao, Tong Gao, Guangyu Huang, Duo Ning, Zemin Cao, Youxin Xu, Weizheng Liang, Simon Zhongyuan Tian et al. · 2024 · Nature Communications
  32. Modeling Cancer in the CRISPR Era
    Andrea Ventura, Lukas E. Dow · 2017 · Annual Review of Cancer Biology
  33. Recent advances in lineage differentiation from stem cells: hurdles and opportunities?
    Joke Terryn, Tine Tricot, Madhavsai K. Gajjar, Catherine M. Verfaillie · 2018 · F1000Research
  34. Identification of on-target mutagenesis during correction of a beta-thalassemia splice mutation in iPS cells with optimised CRISPR/Cas9-double nickase reveals potential safety concerns
    Suad Al-Ateeq, Dmitry A. Ovchinnikov, Timothy J. Tracey, Deanne J. Whitworth, Abdullah M. Al‐Rubaish, Amein K. Al‐Ali, Ernst Jurgen Wolvetang · 2018 · APL Bioengineering
  35. Transcriptomic analyses of gene expression by CRISPR knockout of miR-214 in cervical cancer cells
    Prakriti Sen, Sayam Ghosal, Rudranil Hazra, Solomon Arega, Rimjhim Mohanty, Kirti K. Kulkarni, Roli Budhwar, Niladri Ganguly · 2019 · Genomics
  36. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers
    Surbhi Jain, Guanhua Xun, Shireen Abesteh, Sherri Ho, Manasi Lingamaneni, Teresa A. Martin, Ipek Tasan, Yang Che, Huimin Zhao · 2021 · ACS Synthetic Biology
  37. MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans
    Sudhiranjan Gupta, Rakeshwar S. Guleria, Yvette Z. Szabo · 2021 · Psychiatry Research
  38. Quantitatively Understanding Plant Signaling: Novel Theoretical–Experimental Approaches
    Sophia L. Samodelov, Matias Daniel Zurbriggen · 2017 · Trends in Plant Science
  39. Genome editing technologies to fight infectious diseases
    Marta Trevisan, Giorgio Palù, Luisa Barzon · 2017 · Expert Review of Anti-infective Therapy
  40. Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses
    Mahdi Rivandi, John W.M. Martens, Antoinette Hollestelle · 2018 · Frontiers in Genetics
  41. Dynamic basis of supercoiling-dependent DNA interrogation by Cas12a via R-loop intermediates
    Kevin Aris, Joshua C. Cofsky, Honglue Shi, Noor Al-Sayyad, Ivan E. Ivanov, Ashwin Balaji, Jennifer A. Doudna, Zev D. Bryant · 2025 · Nature Communications
  42. Applications of CRISPR-Cas Technologies to Proteomics
    Georgii V. Dolgalev, Ekaterina Vladimirovna Poverennaya · 2021 · Genes
  43. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective
    Mohamed M. Bekhite, Paul Christian Schulze · 2021 · Cells
  44. Co-Delivery of p53 Restored and E7 Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions
    Jinfeng Xiong, Guannan Li, Xinyu Mei, Jiahui Ding, Hui Shen, Da Zhu, Hui Wang · 2022 · Frontiers in Pharmacology
  45. A Leak-Free Inducible CRISPRi/a System for Gene Functional Studies in Plasmodium falciparum
    Xiaoying Liang, Rachasak Boonhok, Faiza Amber Siddiqui, Bo Xiao, Xiaolian Li, Junling Qin, Hui Min, Lubin Jiang, Liwang Cui, Jun Miao · 2022 · Microbiology Spectrum
  46. Genome editing for biodiesel production in oleaginous microalga, Nannochloropsis species
    Tomokazu Kurita, Masako Iwai, Hiroyuki Ohta, Tetsushi Sakuma, Takashi Yamamoto · 2023 · Gene and Genome Editing
  47. To Crispr And Beyond: The Evolution Of Genome Editing In Stem Cells
    Kuang-Yui Michael Chen, Paul S. Knoepfler · 2016 · Regenerative Medicine
  48. A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing
    Kabin Xie, Yinong Yang · 2019 · Methods in molecular biology
  49. Rapid and Simple Screening of CRISPR Guide RNAs (gRNAs) in Cultured Cells Using Adeno-Associated Viral (AAV) Vectors
    Julia Fakhiri, Manuela Nickl, Dirk Grimm · 2019 · Methods in molecular biology
  50. DNA event recorders send past information of cells to the time of observation
    Soh Ishiguro, Hideto Mori, Nozomu Yachie · 2019 · Current Opinion in Chemical Biology
  51. Genetically Engineering the Nervous System with CRISPR-Cas
    Alfredo Sandoval, Hajira Elahi, Jonathan E. Ploski · 2020 · eNeuro
  52. Application of Various Delivery Methods for CRISPR/dCas9
    Zhixi Liu, Zhi Liao, Yan Chen, Lizhu Han, Qinan Yin, Hongtao Xiao · 2020 · Molecular Biotechnology
  53. CRISPRi/a Screening with Human iPSCs
    Masataka Nishiga, Lei S. Qi, Joseph C. Wu · 2021 · Methods in molecular biology
  54. Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention
    Yusuf M. Idres, Nigel A.J. McMillan, Adi Idris · 2022 · Molecular Diagnosis & Therapy
  55. Gene surgery
    Ayman El-Meghawry El-Kenawy, Bachir Benarba, Adriana Freitas Neves, Thaise Gonçalves Araújo, Bee Ling Tan, Adel Gouri · 2019 · EXCLI journal
  56. CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential
    Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri · 2025 · Cell Proliferation
  57. Gene editing and CRISPR-dependent homology-mediated end joining
    Brian L. Ruis, Anja‐Katrin Bielinsky, Eric A. Hendrickson · 2025 · Experimental & Molecular Medicine
  58. Tailoring non-viral delivery vehicles for transporting genome-editing tools
    Wujin Sun, Zhen Gu · 2016 · Science China Materials
  59. Application of CRISPR-Mediated Gene Editing for Crop Improvement
    Chandranandani Negi, Neeraj Kumar Vasistha, Dharmendra Singh, Pritesh Vyas, Harcharan Singh Dhaliwal · 2022 · Molecular Biotechnology
  60. Emergence of CRISPR/Cas9-mediated bioimaging: A new dawn of in-situ detection
    Tian Meng, Rui Zhang, Jinming Li · 2023 · Biosensors and Bioelectronics
  61. Reprogramming cell fate with artificial transcription factors
    Evan A. Heiderscheit, Asuka Eguchi, Mackenzie C. Spurgat, Aseem Z. Ansari · 2018 · FEBS Letters
  62. The potential application of genome editing by using CRISPR/Cas9, and its engineered and ortholog variants for studying the transcription factors involved in the maintenance of phosphate homeostasis in model plants
    Anupam Jyoti, Sanket Kaushik, Vijay Kumar Srivastava, Manali Datta, Shailesh Kumar, Poli Yugandhar, Shanker Lal Kothari, Vandna Rai, Ajay Jain · 2019 · Seminars in Cell and Developmental Biology
  63. Role of Modern Technologies in Tissue Engineering
    Qurban Ali, Sabeen Malik, Arif Malik, Muhammad Nadeem Hafeez, Said Salman · 2020 · Archives of Neuroscience
  64. Gene therapies for axonal neuropathies: Available strategies, successes to date, and what to target next
    Kathryn H. Morelli, Courtney L. Hatton, Scott Q. Harper, Robert W. Burgess · 2020 · Brain Research
  65. Engineering CRISPR-Cas9 RNA–Protein Complexes for Improved Function and Delivery
    Romain Rouet, Lorena de Oñate, Jie Li, Niren Murthy, Ross C. Wilson · 2018 · The CRISPR Journal
  66. Permutation-Based Causal Structure Learning with Unknown Intervention Targets
    Chandler Squires, Yuhao Wang, Caroline Uhler · 2019 · arXiv (Cornell University)
  67. CrisPR/CRIS systems are highly effective and useful for genomic manipulation. Despite this, cardiac treatment remains difficult due to existing genome editing and delivery processes.
    Moataz Dowaidar · 2021
  68. CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook
    Hanieh Noormohamadi, Hamed Soleimani Samarkhazan, Maryam Kargar, Faezeh Maroufi, Nazli Servatian, Fatemeh Davami · 2025 · Discover Oncology
  69. CRISPR delivery systems for organ-specific targeting: Advances and challenges
    Jun Du, Qinjie Wu, Chao Liu, Ning Wang, Changyang Gong · 2025 · Precision medicine and engineering.
  70. Genetic suppression: Extending our knowledge from lab experiments to natural populations
    Takeshi Matsui, Jonathan T. Lee, Ian M. Ehrenreich · 2017 · BioEssays
  71. Mouse models in the era of large human tumour sequencing studies
    Julian R. de Ruiter, Lodewyk F.A. Wessels, Jos Jonkers · 2018 · Open Biology
  72. Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors
    Yafeng Wang, Guiquan Zhang, Qingzhou Meng, Shisheng Huang, Panpan Guo, Qibin Leng, Lingyun Sun, Geng Liu, Xingxu Huang, Jianghuai Liu · 2022 · Nature Communications
  73. TriTag: an integrative tool to correlate chromatin dynamics and gene expression in living cells
    Haiyue Xu, Junyan Wang, Ying Liang, Yujuan Fu, Sihui Li, Jinghan Huang, Heng Xu, Wei Zou, Baohui Chen · 2020 · Nucleic Acids Research
  74. Integrative dissection of gene regulatory elements at base resolution
    Zeyu Chen, Nauman M. Javed, Molly M. Moore, Jingyi Wu, Gary Sun, Michael E. Vinyard, Alejandro Collins, Luca Pinello, Fadi J. Najm, B Bernstein · 2023 · Cell Genomics
  75. Recent Trends in Enhancing the Resistance of Cultivated Plants to Heavy Metal Stress by Transgenesis and Transcriptional Programming
    Elena S. Belykh, Tatiana A. Maystrenko, Ilya O. Velegzhaninov · 2019 · Molecular Biotechnology
  76. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models
    Mahdi Barazesh, Shiva Mohammadi, Yadollah Bahrami, Pooneh Mokarram, Mohammad Hossein Morowvat, Massoud Saidijam, Morteza Karimipoor, Soudabeh Kavousipour, Amir Reza Vosoughi, Korosh Khanaki · 2020 · Current Gene Therapy
  77. CRISPR/Cas9 genome surgery for retinal diseases
    Christine L. Xu, Karen Sophia Park, Stephen H. Tsang · 2018 · Drug Discovery Today Technologies
  78. SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host–virus interaction studies
    Wenfang Tang, Anh-Tu Tran, Ling‐Yu Wang, Jim‐Tong Horng · 2023 · Biomedical Journal
  79. Mammalian synthetic biology in the age of genome editing and personalized medicine
    Patrick Ho, Yvonne Y. Chen · 2017 · Current Opinion in Chemical Biology
  80. Genetic circuitry for personalized human cell therapy
    Fabian Tölle, Pascal Stücheli, Martin Fussenegger · 2019 · Current Opinion in Biotechnology
  81. Genome Editing: A Tool from the Vault of Science for Engineering Climate-Resilient Cereals
    Rahul Dilawari, Navneet Kaur, Nitesh Priyadarshi, Brijesh Kumar, K. F. Abdelmotelb, Shambhu Krishan Lal, B. P. Singh, Anurag Tripathi, Sumit Kumar Aggarwal, Bahadur Singh Jat et al. · 2021 · Springer eBooks
  82. Non-viral CRISPR activation system targeting VEGF-A and TGF-β1 for enhanced osteogenesis of pre-osteoblasts implanted with dual-crosslinked hydrogel
    Guo Chen, Shaohui Deng, Mingxiang Zuo, Jin Wang, Du Cheng, Bin Chen · 2022 · Materials Today Bio
  83. Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites
    Ana Lúcia Leitão, Marina C. Costa, Francisco J. Enguita · 2016 · Journal of Biotechnology
  84. Advanced Gene Manipulation Methods for Stem Cell Theranostics
    Christopher Rathnam, Sy‐Tsong Dean Chueng, Letao Yang, Ki‐Bum Lee · 2017 · Theranostics
  85. Off and back-on again: a tumor suppressor’s tale
    Jonuelle Acosta, Walter Wang, David M. Feldser · 2018 · Oncogene
  86. Tailored chromatin modulation to promote tissue regeneration
    Paloma Martínez‐Redondo, Juan Carlos Izpisúa Belmonte · 2019 · Seminars in Cell and Developmental Biology
  87. A method for characterizing Cas9 variants via a one-million target sequence library of self-targeting sgRNAs
    András Tálas, Krisztina Huszár, Péter István Kulcsár, Julia K. Varga, Éva Varga, Eszter Tóth, Zsombor Welker, Gergely Erdős, Péter Ferenc Pach, Ágnes Welker et al. · 2021 · Nucleic Acids Research
  88. Design and Generation of a CRISPR Interference System for Genetic Repression and Essential Gene Analysis in the Fungal Pathogen Candida albicans
    Lauren F. Wensing, Rebecca S. Shapiro · 2021 · Methods in molecular biology
  89. Toehold-Based CRISPR-dCas9 Transcriptional Activation Platform for Spatiotemporally Controllable Gene Therapy in Tumor and Diabetic Mouse Models
    Chong Hu, Xiaorui Shi, Bin Guo, Zeping Yang, Jie H. S. Zhou, Fu Wang · 2025 · ACS Nano
  90. CRISPR interference-mediated silencing of pro-inflammatory genes in autoimmune models: functional and biophysical evaluation with sustained effects in primary human PBMCs
    Omar Eladl · 2025 · International Immunopharmacology
  91. Multigene delivery in mammalian cells: Recent advances and applications
    Maysam Mansouri, Philipp Berger · 2018 · Biotechnology Advances
  92. CRISPR/Cas13a targeting of RNA virus in plants
    Kul Bhushan · 2018 · Plant Cell Reports
  93. CRISPR/ddCas12a-based programmable and accurate gene regulation
    Jingman Wang, Anrui Lu, Jin‐Xin Bei, Guoping Zhao, Jin Wang · 2019 · Cell Discovery
  94. High-Throughput Functional Genomics for Energy Production
    Jacob A. Fenster, Carrie A. Eckert · 2020 · Current Opinion in Biotechnology
  95. Genomic selection
    Dayal Nitai Das, Thirumalaisamy Karuthadurai, Shanmugapriya Gnanasekaran · 2020 · Elsevier eBooks
  96. CRISPR/Cas-Mediated Abiotic Stress Tolerance in Crops
    Aftab Ahmad, Sidra Ashraf, Nayla Munawar, Amer Jamil, Abdul Ghaffar, Muhammad Shahbaz · 2021 · Springer eBooks
  97. Optimal, Large-Scale Propagation of Mouse Mammary Tumor Organoids
    Emma D. Wrenn, Breanna M. Moore, Erin Greenwood, Margaux McBirney, Kevin J. Cheung · 2020 · Journal of Mammary Gland Biology and Neoplasia
  98. Experimental Approaches to Identify Host Factors Important for Influenza Virus
    Grace A. Schaack, Andrew Mehle · 2019 · Cold Spring Harbor Perspectives in Medicine
  99. Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma
    Tingting Jia, Feng-Ze Wang, Bo Qiao, Yipeng Ren, Lejun Xing, Haizhong Zhang, Hongbo Li · 2021 · Frontiers in Molecular Biosciences
  100. A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals
    Jianli Yin, Hang Wan, Deqiang Kong, Xingwan Liu, Ying Guan, Jiali Wu, Yang Zhou, Xiaoding Ma, Chunbo Lou, Haifeng Ye et al. · 2024 · Cell Systems